These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34250781)

  • 41. [The use of fibrin-collagen substance in case of spleen injuries].
    Gorskiĭ VA; Agapov MA; Protasov AV; Iskhakov RR
    Khirurgiia (Mosk); 2013; (12):73-7. PubMed ID: 24362297
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of hydroxyethyl cellulose soluble hemostatic gauze on hemostasis in facial contouring surgery.
    Du H; Zhang D; Song G; Zong X; Jin X
    Medicine (Baltimore); 2021 May; 100(19):e25847. PubMed ID: 34106626
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of a vessel sealant device for splenectomy in dogs.
    Rivier P; Monnet E
    Vet Surg; 2011 Jan; 40(1):102-5. PubMed ID: 21062325
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of self-prepared absorbable hemostatic cellulose fibrils.
    Wang L; Tong J; Zhao Z; Yang X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Oct; 50(5):633-641. PubMed ID: 34986534
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative safety and efficacy of topical hemostatic agents in a rat neurosurgical model.
    Ereth MH; Schaff M; Ericson EF; Wetjen NM; Nuttall GA; Oliver WC
    Neurosurgery; 2008 Oct; 63(4 Suppl 2):369-72; discussion 372. PubMed ID: 18981845
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Analysis of opinion of surgeons on the role of topical hemostatic agents].
    Bondarev GA; Lipatov VA; Lazarenko SV; Severinov DA; Saakyan AR
    Khirurgiia (Mosk); 2020; (8):61-68. PubMed ID: 32869617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of an ultrasonically activated scalpel for splenectomy in 10 dogs with naturally occurring splenic disease.
    Royals SR; Ellison GW; Adin CA; Wheeler JL; Sereda CW; Krotscheck U
    Vet Surg; 2005; 34(2):174-8. PubMed ID: 15860110
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CO2 laser and suture in splenic parenchyma: an experimental study.
    Goldenberg A; Goldenberg S; Guidugli Neto J; Chacon JP
    Lasers Surg Med; 1985; 5(4):405-13. PubMed ID: 4033344
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized, controlled, prospective trial to evaluate the haemostatic effect of Lyostypt versus Surgicel in arterial bypass anastomosis: "COBBANA" trial.
    Baumann P; Schumacher H; Hüsing J; Luntz S; Knaebel HP
    Trials; 2009 Sep; 10():91. PubMed ID: 19788736
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of poly-N-acetyl glucosamine with commercially available topical hemostats for achieving hemostasis in coagulopathic models of splenic hemorrhage.
    Schwaitzberg SD; Chan MW; Cole DJ; Read M; Nichols T; Bellinger D; Connolly RJ
    J Trauma; 2004 Jul; 57(1 Suppl):S29-32. PubMed ID: 15280748
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An in vivo comparison of the efficacy of hemostatic powders, using two porcine bleeding models.
    MacDonald MH; Wang AY; Clymer JW; Hutchinson RW; Kocharian R
    Med Devices (Auckl); 2017; 10():273-279. PubMed ID: 29238233
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Control of presacral venous bleeding during rectal surgery.
    Germanos S; Bolanis I; Saedon M; Baratsis S
    Am J Surg; 2010 Aug; 200(2):e33-5. PubMed ID: 20409516
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of surgical hemostasis: topical agents.
    Sileshi B; Achneck HE; Lawson JH
    Vascular; 2008; 16 Suppl 1():S22-8. PubMed ID: 18544302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microporous polysaccharide hemosphere absorbable hemostat use in cardiothoracic surgical procedures.
    Bruckner BA; Blau LN; Rodriguez L; Suarez EE; Ngo UQ; Reardon MJ; Loebe M
    J Cardiothorac Surg; 2014 Aug; 9():134. PubMed ID: 25085116
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hemostatic efficacy of EVARREST™, Fibrin Sealant Patch vs. TachoSil® in a heparinized swine spleen incision model.
    Matonick JP; Hammond J
    J Invest Surg; 2014 Dec; 27(6):360-5. PubMed ID: 25361019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of a Bipolar Vessel-Sealing Device for Splenic Parenchymal Resection in Three Dogs and One Cat.
    Siemon H
    J Am Anim Hosp Assoc; 2021 Jan; 57(1):32-36. PubMed ID: 33260205
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduction in hospital costs and resource consumption associated with the use of advanced topical hemostats during inpatient procedures.
    Martyn D; Kocharian R; Lim S; Meckley LM; Miyasato G; Prifti K; Rao Y; Riebman JB; Scaife JG; Soneji Y; Corral M
    J Med Econ; 2015 Jun; 18(6):474-81. PubMed ID: 25728820
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreased surgical time with a vessel sealing device versus a surgical stapler in performance of canine splenectomy.
    Monarski CJ; Jaffe MH; Kass PH
    J Am Anim Hosp Assoc; 2014; 50(1):42-5. PubMed ID: 24216490
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thermal ablation for partial splenectomy hemostasis, spleen trauma, splenic metastasis and hypersplenism.
    Duan YQ; Liang P
    Hepatogastroenterology; 2013 May; 60(123):501-6. PubMed ID: 23159352
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Partial splenectomy with the CO2 laser: an alternative technique.
    Reynolds M; LoCicero J; Young S; Michaelis LL
    J Surg Res; 1986 Dec; 41(6):580-6. PubMed ID: 3097422
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.